These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 22685331

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.
    Kornegay JN, Bogan DJ, Bogan JR, Dow JL, Wang J, Fan Z, Liu N, Warsing LC, Grange RW, Ahn M, Balog-Alvarez CJ, Cotten SW, Willis MS, Brinkmeyer-Langford C, Zhu H, Palandra J, Morris CA, Styner MA, Wagner KR.
    Skelet Muscle; 2016; 6():14. PubMed ID: 27047655
    [Abstract] [Full Text] [Related]

  • 3. Myostatin/activin blocking combined with exercise reconditions skeletal muscle expression profile of mdx mice.
    Kainulainen H, Papaioannou KG, Silvennoinen M, Autio R, Saarela J, Oliveira BM, Nyqvist M, Pasternack A, 't Hoen PA, Kujala UM, Ritvos O, Hulmi JJ.
    Mol Cell Endocrinol; 2015 Jan 05; 399():131-42. PubMed ID: 25304272
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
    Montgomery E, Pennington C, Isales CM, Hamrick MW.
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep 05; 286(1):814-22. PubMed ID: 16078270
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interference with myostatin/ActRIIB signaling as a therapeutic strategy for Duchenne muscular dystrophy.
    Amthor H, Hoogaars WM.
    Curr Gene Ther; 2012 Jun 05; 12(3):245-59. PubMed ID: 22554312
    [Abstract] [Full Text] [Related]

  • 10. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice.
    Qiao C, Li J, Jiang J, Zhu X, Wang B, Li J, Xiao X.
    Hum Gene Ther; 2008 Mar 05; 19(3):241-54. PubMed ID: 18288893
    [Abstract] [Full Text] [Related]

  • 11. Biological scaffold-mediated delivery of myostatin inhibitor promotes a regenerative immune response in an animal model of Duchenne muscular dystrophy.
    Estrellas KM, Chung L, Cheu LA, Sadtler K, Majumdar S, Mula J, Wolf MT, Elisseeff JH, Wagner KR.
    J Biol Chem; 2018 Oct 05; 293(40):15594-15605. PubMed ID: 30139748
    [Abstract] [Full Text] [Related]

  • 12. Myostatin directly regulates skeletal muscle fibrosis.
    Li ZB, Kollias HD, Wagner KR.
    J Biol Chem; 2008 Jul 11; 283(28):19371-8. PubMed ID: 18453534
    [Abstract] [Full Text] [Related]

  • 13. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia.
    Benny Klimek ME, Aydogdu T, Link MJ, Pons M, Koniaris LG, Zimmers TA.
    Biochem Biophys Res Commun; 2010 Jan 15; 391(3):1548-54. PubMed ID: 20036643
    [Abstract] [Full Text] [Related]

  • 14. Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice.
    Fakhfakh R, Lee SJ, Tremblay JP.
    Cell Transplant; 2012 Jan 15; 21(7):1419-30. PubMed ID: 22449443
    [Abstract] [Full Text] [Related]

  • 15. ActRIIB blockade increases force-generating capacity and preserves energy supply in exercising mdx mouse muscle in vivo.
    Béchir N, Pecchi E, Vilmen C, Le Fur Y, Amthor H, Bernard M, Bendahan D, Giannesini B.
    FASEB J; 2016 Oct 15; 30(10):3551-3562. PubMed ID: 27416839
    [Abstract] [Full Text] [Related]

  • 16. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.
    Nakatani M, Takehara Y, Sugino H, Matsumoto M, Hashimoto O, Hasegawa Y, Murakami T, Uezumi A, Takeda S, Noji S, Sunada Y, Tsuchida K.
    FASEB J; 2008 Feb 15; 22(2):477-87. PubMed ID: 17893249
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of myostatin and follistatin in Mdx mice, an animal model for muscular dystrophy.
    Abe S, Soejima M, Iwanuma O, Saka H, Matsunaga S, Sakiyama K, Ide Y.
    Zoolog Sci; 2009 May 15; 26(5):315-20. PubMed ID: 19715499
    [Abstract] [Full Text] [Related]

  • 20. Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone.
    Iskenderian A, Liu N, Deng Q, Huang Y, Shen C, Palmieri K, Crooker R, Lundberg D, Kastrapeli N, Pescatore B, Romashko A, Dumas J, Comeau R, Norton A, Pan J, Rong H, Derakhchan K, Ehmann DE.
    Skelet Muscle; 2018 Oct 27; 8(1):34. PubMed ID: 30368252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.